Roderick H. O'Reilly - 28 Feb 2023 Form 4 Insider Report for Augmedix, Inc.

Role: Director
Signature: /s/ Todd Holvick, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 28 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 02 Mar 2023, 16:01:37 UTC
Previous filing: 30 Dec 2021
Next filing: 17 Jul 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AUGX	Employee Stock Option (right to buy)	Award	$0	+370,000		$0.000000	370,000	28 Feb 2023	Common Stock	370,000	$1.62	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. Twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the grant date and the remaining shares subject to the Option shall vest subsequently in thirty-six (36) equal monthly increments, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Content

The option is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. Twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the grant date and the remaining shares subject to the Option shall vest subsequently in thirty-six (36) equal monthly increments, subject to the Reporting Person's provision of service to the Issuer on each vesting date.